Be categorized as American Society of Anesthesiologists (ASA) Physical Status Class 1, 2, or 3.
Have a planned non-emergent surgical procedure or clinical situation (e.g., intubation) that requires moderate or deep NMB with either rocuronium or vecuronium.
Have a planned surgical procedure or clinical situation that would allow objective neuromuscular monitoring techniques to be applied with access to the arm for neuromuscular transmission monitoring.
Age between 2 to <17 years at Visit 2.
If female, may participate if she is not pregnant, not breastfeeding, and at least one of the following: 1) Not a woman of childbearing potential (WOCBP); or 2) A WOCBP who agrees to follow the study contraceptive guidance during the treatment period and for at least 7 days after the last dose of study treatment.

NCT03351608_inc_T1
Measurement
American Society of Anesthesiologists (ASA) Physical Status Class
NCT03351608_inc_T2
Value
1
NCT03351608_inc_T3
Value
2
NCT03351608_inc_T4
Value
3
NCT03351608_inc_T5
Scope
1, 2, or 3
NCT03351608_inc_T6
Mood
planned
NCT03351608_inc_T7
Qualifier
non-emergent
NCT03351608_inc_T8
Procedure
surgical procedure
NCT03351608_inc_T9
Condition
clinical situation
NCT03351608_inc_T10
Procedure
intubation
NCT03351608_inc_T11
Scope
clinical situation (e.g., intubation)
NCT03351608_inc_T12
Procedure
NMB
NCT03351608_inc_T13
Qualifier
moderate
NCT03351608_inc_T14
Qualifier
deep
NCT03351608_inc_T15
Scope
moderate or deep
NCT03351608_inc_T16
Drug
rocuronium
NCT03351608_inc_T17
Drug
vecuronium
NCT03351608_inc_T18
Scope
rocuronium or vecuronium
NCT03351608_inc_T19
Mood
planned
NCT03351608_inc_T20
Procedure
surgical procedure
NCT03351608_inc_T21
Condition
clinical situation
NCT03351608_inc_T22
Procedure
objective neuromuscular monitoring techniques
NCT03351608_inc_T23
Qualifier
that would allow objective neuromuscular monitoring techniques to be applied
NCT03351608_inc_T24
Scope
planned surgical procedure
NCT03351608_inc_T25
Person
Age
NCT03351608_inc_T26
Value
between 2 to <17 years
NCT03351608_inc_T27
Temporal
at Visit 2
NCT03351608_inc_T28
Person
female
NCT03351608_inc_T29
Negation
not
NCT03351608_inc_T30
Condition
pregnant
NCT03351608_inc_T31
Negation
not
NCT03351608_inc_T32
Observation
breastfeeding
NCT03351608_inc_T33
Multiplier
at least one
NCT03351608_inc_T34
Condition
woman of childbearing potential (WOCBP)
NCT03351608_inc_T35
Negation
Not
NCT03351608_inc_T36
Condition
WOCBP
NCT03351608_inc_T37
Procedure
contraceptive guidance
NCT03351608_inc_T38
Temporal
during the treatment period
NCT03351608_inc_T39
Temporal
for at least 7 days after the last dose of study treatment
NCT03351608_inc_T40
Reference_point
the last dose of study treatment
NCT03351608_inc_T41
Reference_point
the treatment period
NCT03351608_inc_T42
Scope
during the treatment period and for at least 7 days after the last dose of study treatment
NCT03351608_inc_T43
Scope
WOCBP who agrees to follow the study contraceptive guidance during the treatment period and for at least 7 days after the last dose of study treatment
NCT03351608_inc_T44
Scope
Not a woman of childbearing potential (WOCBP)
NCT03351608_inc_T45
Scope
Not a woman of childbearing potential (WOCBP); or 2) A WOCBP who agrees to follow the study contraceptive guidance during the treatment period and for at least 7 days after the last dose of study treatment
NCT03351608_inc_T46
Scope
not pregnant, not breastfeeding, and at least one of the following: 1) Not a woman of childbearing potential (WOCBP); or 2) A WOCBP who agrees to follow the study contraceptive guidance during the treatment period and for at least 7 days after the last dose of study treatment